The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice

Alcohol

Volumn 42, Issue 2, 2008, Pages 123-127

  Jerlhag, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Amphetamine; Aripiprazole; Ethanol; Locomotor activity

Indexed keywords

ALCOHOL; ARIPIPRAZOLE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ALCOHOL INTERACTION; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; LOCOMOTION; MALE; MOUSE; NONHUMAN; REWARD;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; ETHANOL; MALE; MICE; MOTOR ACTIVITY; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE D2;

MUS;

EID: 40749086262     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2007.11.004     Document Type: Article

References (47)

1. Blomqvist O., Söderpalm B., and Engel J.A. 5-HT1A receptor agonists reduce ethanol-induced locomotor activity in mice. Alcohol 11 (1994) 157-161
2. Burris K.D., Molski T.F., Xu C., Ryan E., Tottori K., Kikuchi T., Yocca F.D., and Molinoff P.B. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 302 (2002) 381-389
3. Carlsson M.L., Carlsson A., and Nilsson M. Schizophrenia: from dopamine to glutamate and back. Curr. Med. Chem. 11 (2004) 267-277
4. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 237-260
5. El-Sayeh H.G., Morganti C. (2004) Aripiprazole for schizophrenia. Cochrane Database Syst Rev 2006, Issue 2. Art. No.: CD004578.
6. Engel J.A. Neurochemical aspects of the euphoria induced by dependence-producing drugs. Recent Advances in the Study of Alcoholism (1977), Excerpta Medica, Amsterdam 16-22
7. Engel J.A., and Carlsson A. Catecholamines and behavior. In: Valzelli L., and Essman W.B. (Eds). Current Development in Psychopharmacology (1977), Spectrum Publishing, New York 1-32
8. Engel J.A., Falkhe C., Hård E., Johannessen K., Svensson L., and Söderpalm B. Serotonergic and dopaminergic involvement in ethanol intake. Clin. Neuropharmacol. 15 (1992) 64A-65A
9. Gabby F.H. Family history of alcoholism and response to amphetamine: sex differences in the effect of risk. Alcohol. Clin. Exp. Res. 29 (2005) 773-780
10. Hedlund L., and Wahlstrom G. Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism. Alcohol Clin. Exp. Res. 23 (1999) 822-827
11. Heinz A., Siessmeier T., Wrase J., Buchholz H.G., Grunder G., Kumakura Y., Cumming P., Schreckenberger M., Smolka M.N., Rosch F., Mann K., and Bartenstein P. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am. J. Psychiatry 162 (2005) 1515-1520
12. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96 (2000) 651-656
13. Hutchison K.E., Wooden A., Swift R.M., Smolen A., McGeary J., Adler L., and Paris L. Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 28 (2003) 1882-1888
14. Imperato A., and Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239 (1986) 219-228
15. Ingman K., Kupila J., Hyytia P., and Korpi E.R. Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. Alcohol Alcohol 41 (2006) 391-398
16. Kenna G.A., McGeary J.E., and Swift R.M. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2. Am. J. Health Syst. Pharm. 61 (2004) 2380-2388
17. Knutson B., Adams C.M., Fong G.W., and Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21 (2001) 1-5
18. Le A.D., Tomkins D., Higgins G., Quan B., and Sellers E.M. Effects of 5-HT3, D1 and D2 antagonists on ethanol-and cocaine-induced locomotion. Pharmacol. Biochem. Behav. 57 (1997) 325-332
19. Lile J.A., Stoops W.W., Vansickel A.R., Glaser P.E., Hays L.R., and Rush C.R. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology 30 (2005) 2103-2114
20. Liu X., and Weiss F. Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J. Pharmacol. Exp. Ther. 300 (2002) 882-889
21. Martinez D., Gil R., Slifstein M., Hwang D.R., Huang Y., Perez A., Kegeles L., Talbot P., Evans S., Krystal J., Laruelle M., and Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol. Psychiatry. 58 (2005) 779-786
22. Meert T.F. Effects of various serotonergic agents on alcohol intake and preference in Wistar rats selected at two different levels of alcohol preference. Alcohol Alcohol 28 (1993) 157-170
23. Monnelly E.P., Ciraulo D.A., Knapp C., LoCastro J., and Sepulveda I. Quetiapine for treatment of alcohol dependence. J. Clin. Psychopharmacol. 24 (2004) 532-535
24. Pfeffer A.O., and Samson H.H. Oral ethanol reinforcement: interactive effects of amphetamine, pimozide and food restriction. Alcohol. Drug Res. 6 (1985) 37-48
25. Pfeffer A.O., and Samson H.H. Haloperidol and apomorphine effects on ethanol reinforcement in free-feeding rats. Pharmacol Biochem. Behav. 19 (1988) 343-350
26. Potenza M.N., Steinberg M.A., Skudlarski P., Fulbright R.K., Lacadie C.M., Wilber M.K., Rounsaville B.J., Gore J.C., and Wexler B.E. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch. Gen. Psychiatry 60 (2003) 828-836
27. Potvin S., Stip E., and Roy J.Y. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. Int. Clin. Psychopharmacol. 18 (2003) 121-132
28. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
29. Stoops W.W., Lile J.A., Glaser P.E., and Rush C.R. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend. 84 (2006) 206-209
30. Tamminga C.A., and Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 141-147
31. Thiihonen J., Kuoppasalmi K., Fohr J., Tuomola P., Kuikanmaki O., Vorma H., Sokero P., Haukka J., and Meririnne E. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am. J. Psychiatry 164 (2007) 160-162
32. Uzun S., Kozumplik O., Mimica N., and Folnegovic-Smalc V. Aripiprazole: an overview of a novel antipsychotic. Psychiatr. Danub 17 (2006) 67-75
33. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., and Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158 (2001) 2015-2021
34. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: insights from imaging studies. J. Clin. Invest. 111 (2003) 1444-1451
35. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., and Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14 (1993) 169-177
36. Volkow N.D., Fowler J.S., Wolf A.P., Schlyer D., Shiue C.Y., Alpert R., Dewey S.L., Logan J., Bendriem B., and Christman D. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am. J. Psychiatry 147 (1990) 719-724
37. Volkow N.D., and Li T.-K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 5 (2004) 963-970
38. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Hitzemann R., Ding Y.S., Pappas N., Shea C., and Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin. Exp. Res. 20 (1996) 1594-1598
39. Waller M.B., Murphy J.M., McBride L., Lumeng L., and Li T.-K. Effects of low-dose of ethanol on spontaneous locomotor activity in alcohol-preferring and nonpreferring rats. Pharmacol. Biochem. Behav. 24 (1986) 617-623
40. Wang G.J., Volkow N.D., Fowler J.S., Logan J., Abumrad N.N., Hitzemann R.J., Pappas N.S., and Pascani K. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16 (1997) 174-182
41. Wang G.J., Volkow N.D., Thanos P.K., and Fowler J.S. Similarity between obesity and drug addiction as assessed by neuro-functional imaging: a concept review. J. Addict Dis. 23 (2004) 30-53
42. Weiss F., Mitchiner M., Bloom F.E., and Koob G.F. Free-choice responding for ethanol versus water in alcohol-preferring (P) and unselected Wistar rats is differentially altered by naloxone, bromocriptine and methysergide. Psychopharmacology 101 (1990) 178-186
43. Winans E. Aripiprazole. Am. J. Health. Syst. Pharm. 60 (2003) 2437-2445
44. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psych. Rev. 94 (1987) 469-492
45. Wise R.A., and Rompré P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225
46. Yokoi F., Grunder G., Biziere K., Stephane M., Dogan A.S., Dannals R.F., Ravert H., Suri A., Bramer S., and Wong D.F. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27 (2002) 248-259
47. Yoshida M., Yokoo H., Mizoguchi K., Kawahaara H., Tsuda A., Nishikawa T., and Tanaka M. Eating and drinking causes increased dopamine release in the nucleus accumbens and ventral tegmental area in rat: measurement by in vivo microdialysis. Neurosci. Lett. 139 (1992) 73-76